N. Ward

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma.

E. Bouffet, T. Philip, J. Michon, 1998, European journal of cancer.

Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection

W. Rozenbaum, N. Clumeck, F. Castelli, 1996, AIDS.